1359 NTX-0471, engineered multivalent SIRPa and bispecific SIRPa-antiCCR4 molecules demonstrate superior activity providing path for mRNA expressed in-vivo biologics

• Weiqun Liu,
• Meredith Leong,
• Evan McCartney-Melstad,
• Colin McKinlay,
• Adrienne Sallets,
• Samuel Deutsch,
• Gunasekaran Kannan,
• Gowrisudha Adusumilli,
• Srinivasa Bandi,
• Shruti Lal,
• Ray Low,
• Ole Audun Haabeth,
• Pei-Ken Hsu,
• Kimmy Ferry,
• Anustha Sharma,
• Jenna Triplett

Affiliations

Weiqun Liu

1Nutcracker Therapeutics, Emeryville, CA, USA

Meredith Leong

Aff1 grid.417411.6Aduro BioTech Berkeley CA USA

Evan McCartney-Melstad

Nutcracker Therapeutics, Emeryville, CA, USA

Colin McKinlay

1Nutcracker Therapeutics, Emeryville, CA, USA

Adrienne Sallets

1Nutcracker Therapeutics, Emeryville, CA, USA

Samuel Deutsch

1Nutcracker Therapeutics, Emeryville, CA, USA

Gunasekaran Kannan

Nutcracker Therapeutics, Emeryville, CA, USA

Gowrisudha Adusumilli

Nutcracker Therapeutics, Emeryville, CA, USA

Srinivasa Bandi

Nutcracker Therapeutics, Emeryville, CA, USA

Shruti Lal

Nutcracker Therapeutics, Emeryville, CA, USA

Ray Low

Nutcracker Therapeutics, Emeryville, CA, USA

Ole Audun Haabeth

Nutcracker Therapeutics, Emeryville, CA, USA

Pei-Ken Hsu

Nutcracker Therapeutics, Emeryville, CA, USA

Kimmy Ferry

Nutcracker Therapeutics, Emeryville, CA, USA

Anustha Sharma

Nutcracker Therapeutics, Emeryville, CA, USA

Jenna Triplett

Nutcracker Therapeutics, Emeryville, CA, USA